CClinicalTrials.gg
CompletedNCT03916263Updated Aug 7, 2023

Low Starch Dietary Education Program vs. Traditional Treatment for PCOS

An Early Phase 1 interventional study of Metformin and One-On-One Dietary Instruction in PCOS, Diet Modification and Metabolism, sponsored by Texas Tech University Health Sciences Center. Completed at 1 site in United States. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-08-07.

Sponsored by Texas Tech University Health Sciences Center · Early Phase 1, Interventional, and Treatment

From the registry’s dates

  • Primary completion was Oct 2022, 3 years 11 months ago, and no results have been posted to the registry.
  • Registered 4 months after the study started (first participant enrolled Aug 2018, registered Jan 2019).
Phase
Early Phase 1
Study type
Interventional
Enrollment
71
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

Compare weight loss and metabolic parameters in patients using a low starch dietary education program vs. traditional treatment (i.e., prescribing metformin, low calorie diet and exercise) for health improvement in women with PCOS.

Read the detailed description

Polycystic ovary syndrome (PCOS) is a common gynecologic condition diagnosed by the presence of irregular menstruation, high androgen levels and polycystic appearing ovaries by ultrasound. PCOS affects approximately 5 million women of reproductive age in the United States and is associated with increased risk of obesity, diabetes, cardiovascular disease, cancer and infertility. Women with PCOS are at 5- to 10-fold risk of developing type 2 diabetes and are diagnosed on average 30 years sooner than women without PCOS. Historically, high insulin levels worsen symptoms of PCOS and make weight loss very difficult despite the patient's best efforts. Research shows that carbohydrates from dairy and starch-based foods have greater insulin-producing properties than carbohydrates from non-starchy vegetables and fruits. The purpose of this study is to compare metabolic parameters in patients using a low starch dietary education program vs. traditional treatment (i.e., prescribing metformin, low calorie diet and exercise) for health improvement in women with PCOS.

In the investigator's previous work, study participants received approximately 1.5 hours of one-on-one dietary instruction by a Registered Dietitian. Dietary instruction included review of a list of foods that participants could eat with no restrictions as well as a list of foods to avoid, i.e. grains and dairy products. Study participants, all of whom were overweight or obese, achieved an average weight loss of 18.9 pounds in 8 weeks. In addition, study participants demonstrated improvements in triglycerides, total and free testosterone and in clinical hair growth scores. This study will investigate whether the same positive results might be achieved using a web-based written and video program for dietary guidance. If successful, the dietary video instructions may potentially benefit a large number of women by providing health care providers with a practical and affordable method to provide dietary instructions to their patients with PCOS, especially in areas where access to a Registered Dietitian is limited.

The goal of this prospective, randomized, controlled, clinical trial is to develop a practical, clinically useful web-based tool for health care providers to educate their patients on an optimal eating plan to manage PCOS.

AIM:

1.Compare weight loss and metabolic parameters in patients using a low starch dietary education program vs. traditional treatment (i.e., prescribing metformin, low calorie diet and exercise) for health improvement in women with PCOS.

METHODS:

Sixty overweight women with PCOS will be recruited to participate in an 8-week low starch diet with pre- and post-study measurements of weight, body mass index, waist to hip ratio, fasting glucose and insulin, complete lipid panel, free and total testosterone, and hemoglobin A1c. Patients will be randomized 1:1 to receive web-based instruction for a low starch diet or to receive face to face nutritional and diet information, or to receive a traditional care plan (metformin if indicated, low calorie diet, and exercise).

02

Conditions studied

  • PCOS
  • Diet Modification
  • Metabolism
  • Nutrition Disorders

Browse trials for

Keywords

  • PCOS
  • Diet
  • Video Instruction
03

In context

Nutrition Disorders

275 studies on the registry are indexed under Nutrition Disorders; 31 are open to participants now.

This study's enrollment of 71 is below the median of 117 across 194 interventional studies indexed under Nutrition Disorders.

Browse Nutrition Disorders studies →

Lead sponsor

Texas Tech University Health Sciences Center is the lead sponsor of 97 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Women ages 18-45
  • BMI of >25 but \< 45
  • PCOS
  • Access to a computer/phone/electronic device with internet connection.

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Abnormal thyroid stimulating hormone (TSH)
  • Hyperprolactinemia
  • adrenal hyperplasia
  • Cushing's disease Ovarian and adrenal tumors. Previous diagnosis of diabetes. History of eating disorder History of surgical weight loss procedure Persons with an inability to give informed consent Persons unable/unwilling to exercise or to prepare their own food
05

Study design

Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
71 participants (actual)

Study arms

  • Experimental
    Traditional Treatment

    Participant receives recommendations for caloric intake, exercise and prescription for metformin if indicated

    Drug: Metformin

  • Other
    One-On-One Low Starch Dietary Instruction

    Participant receives One-On-One Low Starch Dietary Instruction from Study Collaborator

    Other: One-On-One Dietary Instruction

  • Other
    Low Starch Dietary Instruction by Video

    Participant receives Low Starch Dietary Instruction by Video Link

    Other: Video Dietary Instruction

Interventions

  • DrugMetformin

    Traditional care including diet, exercise and metformin

    Also known as: Traditional care

  • OtherOne-On-One Dietary Instruction

    Participant receives one-on-one dietary counseling from study personnel

  • OtherVideo Dietary Instruction

    Participant receives video dietary instruction

06

What researchers measure

Primary outcomes

  1. Weight

    Weight

    Time frame: 8 weeks

  2. BMI

    BMI

    Time frame: 8 weeks

Secondary outcomes

  1. waist to hip ratio

    waist to hip ratio

    Time frame: 8 weeks

  2. fasting glucose

    fasting glucose

    Time frame: 8 weeks

  3. fasting insulin

    fasting insulin

    Time frame: 8 weeks

  4. cholesterol

    cholesterol

    Time frame: 8 weeks

  5. testosterone

    testosterone

    Time frame: 8 weeks

  6. hemoglobin A1c

    hemoglobin A1c

    Time frame: 8 weeks

07

Study locations

1 site
  • Texas Tech Health Science Center
    Lubbock, Texas 79430, United States
08

References and documents

Individual participant data

Plan to share: Yes — Will post to Clinical Trials

Supporting information: Study protocol, Sap, Icf, Csr, Analytic code

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 7, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03916263
Lead sponsor
Texas Tech University Health Sciences Center
Responsible party
Sponsor
First posted
Apr 16, 2019
Start date
Aug 29, 2018
Primary completion
Oct 10, 2022
Completion
Dec 31, 2022
Last update
Aug 7, 2023

Study contacts

Jennifer L Phy, DO
principal investigator · Texas Tech University Health Sciences Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion